Dyne Therapeutics, Inc. <DYN.O>: Baird cuts target price to $26 from $30
DYN•Related News
Oklo Inc. <OKLO.N>: Piper Sandler initiates coverage with Overweight rating; target price $55
OKLO•
Iran attacks US base in Jordan, ships near Hormuz after tankers sunk
XLE•
Grains-Chicago corn falls ahead of USDA's supply demand report
DBA•
Silver Lake Partners IV disposes of Dell common shares worth $71.98 million
DELL•
Braze releases transcript of fiscal Q2 2027 earnings call
BRZE•